News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Benjamin Besse: Should we infuse IO in the morning?
Photo taken from Benjamin Besse/Twitter
May 23, 2024, 14:25

Benjamin Besse: Should we infuse IO in the morning?

Benjamin Besse, Head of Clinical Research on Gustave Roussy, shared on X:

“Should we infuse IO in the morning? Intriguing work just published: Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy. .

We may need to analyze timing of IO infusion in phase III trials to guide us in our daily clinic.”

Read further.
Source: Benjamin Besse/X

Benjamin Besse cancer Circadian tumor infiltration Gustave Roussy immunotherapy IO OncoDaily Oncology
Blog
Jun 30, 2024, 12:56
Vivek Subbiah: A delight to interview Dr. Kemi Doll
Blog
Jun 30, 2024, 12:50
The Kayula Childhood Cancer Foundation is one of the Home Away From Home grant recipients - CCI
Blog
Jun 30, 2024, 12:42
Chris Poulios: 5 full days of interactive classes for Molecular Pathology on various cancer types
Blog
Jun 30, 2024, 12:42
Joshua Muia: Two posters on the enzyme ADAMTS13 being a biomarker in sepsis at ISTH
Blog
Jun 30, 2024, 12:37
Lucy needs our help. We need yours - Children's Cancer Institute
Blog
Jun 30, 2024, 12:36
Helena Linardou: Workshop on AI in Oncology on applications and challenges
Blog
Jun 30, 2024, 12:27
Clare Isacke was awarded the MRS Women in Science Award - Metastatic Research Society
Insight
Jun 30, 2024, 12:27
Myeloma Paper of the Day, June 30th, suggested by Robert Orlowski
Societies
Jun 30, 2024, 12:25
The role of biomarkers in Chemotherapy-Induced Peripheral Neurotoxicity
Blog
Jun 30, 2024, 12:12
Aaron Goodman: Ask the following question to your oncologist
Insight
Jun 30, 2024, 12:05
The situation around GEP-MiNENs in Italy
Blog
Jun 30, 2024, 12:02
Improving quality of life after breast cancer treatment